For more than 50 years Dr. Schwartz has relentlessly investigated in detail the congenital long QT syndrome for which he is now recognized worldwide as the leading expert. His efforts have been made possible in part by securing funding from the National Institute of Health (NIH) without interruption for 43 years, unparalleled by any other European Investigator.

He has defined the multiple clinical characteristics of the disease and have contributed to the identification of several of the LQTS genes. He has performed the pioneering studies in the relationship between genotype and phenotype, which represents a “bridge” between molecular biology and clinical cardiology. As an example, he has provided uniquely large data on the relation between specific genetic subgroups and the factors (“triggers”) involved in the of initiation of the life-threatening arrhythmias of this disorder.

His contribution to the understanding of the relation between genotype and phenotype has opened the fields of gene-specific therapy and of the identification of “modifier genes”.

During this Honorary guest lecture, Peter will take us through parts of his extraordinary more than half-century long journey between LQT Patients and Genes.

NOTICE: No registration is required to attend this guest lecture.